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In view of the preceding  results t obtained with  chick fibroblasts  and avian 
viruses, it appeared desirable  to study the properties of other cells transformed 
bv different viruses. This is  important in order to provide additional  informa- 
tion bearing both on the generality and on the determinants of specificity of the 
observed phenomena. 
Materials aJzd Methods 
The materials and methods are exactly as described for the analogous experimental systems 
examined in the accompanying report. I 
RESULTS 
Hamster Embryo Cells Transformed  by SV-40.-- 
Transformed  hamster fibrinolysin:  cell  factor:  serum factor:  serum speci~gcity: 
The second system that was investigated consisted of primary cultures of ham- 
ster embryo cells, some of which had been transformed by SV-40 virus. A clone 
was isolated (Methods)  and was judged to be transformed by the following cri- 
teria: positive for SV-40 nuclear T-antigen using fluorescent antibody staining, 
disordered  cell  orientation,  multi-layered  growth,  and  growth  in  soft agar. 
When plated on Petri dishes coated with [t2:'I]fibrin  films, SV-40-transformed 
hamster  cultures  exhibit fibrinolytic activity, whereas  cultures of normal cells 
do not; this is shown by the data in Table I  and the serum specificity for this 
activity is presented  in Table II. To test for the elaboration  of a  specific cell 
factor comparable to that produced by transformed chick cells, carefully washed 
monolayers were incubated overnight with serum-free medium and the resulting 
supernatant fluids were tested for fibrinolytic activity both alone and after addi- 
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TABLE  I 
Fibrinolytic  Activity  of Some Normal  and  Transformed  Mammalian  Fibroblasts 
Radioactivity released  in medium (percent  of total) 
% 
Control (no cells)  1.2 
Normal hamster  1.4 
SV40-transformed hamster  31 
Normal mouse C57BL  1.65 
MSV-transformed C57BL  9.6 
Petri dishes (60 mm diameter) containing [125I]fibrin (10/zg/cm2; total radioactivity 105 
cpm) were prepared as described in Methods. Cells were plated at 2 X  105 cells per dish in 
F10 medium supplemented with 10% fetal bovine serum. Medium was removed for radio- 
activity assay at daily intervals and replaced with fresh medium. The values given in the 
table represent the total  radioactivity accumulated in  the medium  between 24  and  48  h 
after plating. 
TABLE  II 
Fibrindytic  Activity  of Hamster  Embryo  Fibroblasts  Transformed  by  SV-40:  EA~ects of 
Dij~erent Sera 
Radioactivity released  into growth  medium (percent  of total) 
Test sara 
Serum concentration  (vol/vol)  :  1%  10% 
%  % 
Fetal bovine  1.3  1.2 
Bovine  1.4  1.3 
Turkey  1.4  1.2 
Chicken  1.5  1.3 
Guinea pig  1.7  2.2 
African green monkey  2.5  25 
Dog  3.5  18 
Hamster  2.2  25 
Petri dishes (60 mm diameter) containing [125I]fibrin (10 #g/cm2; total radioactivity 106 
cpm per dish) were prepared as described in Methods. Hamster cells transformed by SV-40 
were plated in medium containing 10% of fetal bovine serum at a density of 2.2  X  105 cells 
per dish. After 24 h  of incubation the cells were washed with TD and changed to medium 
with one of the indicated sara.  The  medium was removed and  assayed for radioactivity 
after 16 h. 
tion of a variety of sera. As seen in Table III, neither transformed culture HF  ~ 
alone  nor  an  Eagle's serum-free  medium  contains  any detectable  fibrinolytic 
activity; however when the HF from transformed cultures is mixed with an ap- 
propriate  serum,  enzymatic activity is produced.  As is  the  case with  normal 
2 Abbreviations  used  in this  paper:  HF, cell-free  and serum-free culture superuatant fluid 
obtained by incubating monolayer cultures with Eagle's medium (see Materials and Meth- 
ods,  part  I);  MSV,  mouse sarcoma virus;  NPGB,  nitrophenyl-p-guanidinobenzoate (19); 
RAV, Rous-associated virus; RSV, Rous sarcoma virus; SR-RSV, Schmidt-Ruppin strain of 
Rous sarcoma virus; STI,  soybean trypsin inhibitor, fraction VI  (29);  TS-5-SR-RSV, tem- 
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TABLE III 
Fibrinolytic  Activity  of HF  From  Cultures  Of Hamster  Cells  Transformed  by  SV-40  Virus: 
Effects of D(~erent Sera 
Radioactivity released  into 
Test fluid  Serum  solution  (percent of total) 
% 
~{edium  None  0.6 
Medium  Dog  0.5 
Normal hamster HF  Dog  0.6 
Hamster--SV-40 HF  None  0.6 
"  "  "  Dog  41.5 
"  "  "  Hamster  35.1 
"  "  "  African green, monkey  17.5 
"  "  "  Human  8.6 
"  "  "  Chicken  1.2 
"  "  "  Calf  0.9 
"  "  "  Fetal bovine  0.6 
Petri  dishes  (35  mm  diameter)  containing  [12aI]fibrin (10 gg/cm2;  total  radioactivity 
5 X  104 cpm)  were prepared as described  in Methods. The appropriate serum was  added 
to HF or medium to yield a final serum concentration of 2.5%  (vol/vol) in a final volume of 
1 ml. Incubation was for 5 h at 36°C. 
chick cells, HF from normal hamster embryo cultures shows very little fibrino- 
lytic activity. Thus  SV-40 hamster  cultures,  like Rous sarcoma virus (RSV)- 
transformed chick fibroblasts, produce a factor that must interact with a second 
protein from suitable sera to generate fibrinolysin. 
It is of interest to compare the findings in Table III with the previous results 
given by chick cell HF (Table VI of part P). In the case of chick cell HF, normal 
chicken and monkey sera yield the highest rates of fibrinolysis. The fibrinolytic 
activity with  S V-40 hamster HF  differs from  that found with  chick cell HF: 
with SV-40 hamster HF the most efficient activating sera are those of dog, ham- 
ster, and monkey. As shown previously for chick cell HF, some of the "nonacti- 
rating"  sera behave  as  though  they  contain  inhibitors.  Fetal bovine  serum, 
which  belonged in  this  category for  the  chick system,  is inhibitory with  the 
SV-40 hamster system as well (Table IV). The fibrinolytic activity derived from 
hamster  cell  cultures  is  also  inhibited  by  nitrophenyl-p-guanidinobenzoate 
(NPGB) and by the same soybean trypsin inhibitor (STI) that blocks the action 
of chick enzyme (Table IV). 
Parallel  changes  in  morphology  and fibri~olytic  activity:  Since  the  hamster 
cells transformed by SV-40 have been cloned, the cell morphology is rather uni- 
form under any given set of culture conditions. This provides the opportunity 
for  correlating modifications in  cell morphology both  with  changes  in  serum 
supplements and with the accompanying fibrinolytic activity. Correlations of 
this type are illustrated in Figs. 1,  2, and 3. 
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TABLE IV 
Fibrinolysis  by HF from  Hamster Cells Transformed by SV-40: Effect of Various  Inhibitors 
Dog serum (2.5%)  Inhibitor  Radioactivity released into  Percent 
solution  (percent of total)  inhibition 
%  % 
+  None  41.6 
+  Fetal bovine serum (2.5%)  0.6  98.6 
+  Fetal bovine serum (0.6%)  0.6  98.6 
+  Fetal bovine serum (0.3%)  4.5  90.0 
--  Fetal bovine serum (2.5%)  0.6 
--  None  0.7 
+  STI*  100 #g/ml  0.6  98.6 
+  STI  20 #g/ml  0.6  98.6 
+  STI  10 #g/ml  1.1  97.4 
+  STI  1/zg/ml  26.0  37.5 
-4-  NPGB  40 #g/ml  0.6  98.6 
Petri  dishes (35  mm  diameter)  containing  [125I]fibrin (10 .ug/cm2; total  radioactivity 
5 )< 104 cpm) were prepared as described in Methods. The inhibitor was added to HF from 
SV40-transformed  hamster fibroblast cultures at the desired concentration,  followed by dog 
serum at a final concentration  of 2.5%  (vol/vol).  The degree of inhibition  is based on the 
level of fibrinolysis observed with dog serum in absence of inhibitor  (top line). 
* Soybean trypsin inhibitor, fraction VI. 
transformed hamster ceils under various conditions. All of these cultures were 
grown in Dulbecco modified Eagle's medium  containing either  nonactivating 
fetal bovine serum  (10%  vol/vol),  or dog serum  (10%  vol/vol),  which  yields 
maximal fibrinolytic activity. The growth pattern  (or morphology) of normal 
hamster cells is similar in the two tested sera (Fig. 1 a,  1 b). The SV-40-trans- 
formed hamster  cells grown in fetal bovine serum  (Fig.  1 c) form a  confluent 
layer resembling that of normal cells; however, transformed cells grown in dog 
serum  (Fig.  1 d)  show a  striking  change in  morphology: they  are  highly re- 
fractile,  clumped,  and  retracted  from  the  monolayer.  When  maintained  in 
media  supplemented  with  dog  serum  the  transformed  cells  retain  viability, 
although they ultimately detach from the surface of the culture and continue 
to multiply "in suspension." The clumps formed in this way may be harvested 
by centrifugation  at low speeds and transferred  to fresh media. Upon transfer 
to media containing fetal bovine serum the clumps settle  and the constituent 
cells reattach  to the surface and regain the original morphology (Fig. 2 a).  In 
contrast,  when  returned  to  media  supplemented  with  dog  serum,  the  trans- 
formed cells persist  as large clumps  (Fig.  2  c). The soybean trypsin  inhibitor 
that blocks fibrinolytic activity generated in dog serum medium also prevents 
the morphology that develops with dog serum (Fig. 2 b). 
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FIG.  1.  Morphology of normal and SV40-transformed hamster cells: response to different 
sera.  Primary  hamster embryo fibroblasts and  hamster  SV-40-transformed  fibroblasts were 
plated  at  2  X  105 cells per 60 mm dish in Dulbecco modified Eagle's medium with  10%  of 
fetal bovine serum. After  16 h  the cultures were washed twice with medium and incubated 
for 52  h  in Dulbecco medium with fetal bovine or dog serum (10%  final concentration).  (a) 
Normal  cells  in fetal bovine serum;  (~)  normal cells in  dog serum,  (c)  transformed  cells in 
fetal bovine serum; (d)  transformed cells in dog serum. )<  230. OSSOWSKI, UNKELESS, TOBIA, QUIGLEY, RIFKIN, REICH  117 
FIG. 2.  Morphology of hamster embryo cells transformed by SV-40 virus: effects of some 
sera and  of soybean trypsin inhibitor. Hamster embryo fibroblasts  transformed  by SV-40 
were grown for 3 days in medium containing 10% of dog serum. The clumps of growing cells 
which  were largely detached from  the monolayer  were  collected  by centAfugation  and  re- 
suspended  and plated in fresh medium  supplemented  either with dog serum  (10%)  or with 
fetal bovine serum  (10%).  One culture growing in dog serum also received soybean trypsin 
inhibitor (fraction VI) at a concentration of 50/~g/ml. The photomicrographs  were taken 72 
h  after plating. (a)  SV40 hamster ceils in fetal bovine serum  medium;  (b)  SV40 hamster 
cells in dog serum  medium  with soybean trypsin inhibitor; (c)  SV40 hamster cells in dog 
serum medium.  X 66. 
ments we have found additional correlations between fibrinolytic activity and 
cell morphology. Thus,  SV-40 hamster cells grown in media containing chicken 
serum, a nonactivating serum for fibrinolysis, show the same morphology (Fig. 
3  a)  as do cells in fetal bovine serum (Fig. 2  a). Monkey serum,  an activating 
serum, has the same effect on morphology (Fig. 3 b) as dog serum (Fig. 3 c). A 
further instance of a parallel change involving fibrinolytic activity and another 
parameter of transformation is shown by the effect of soybean trypsin inhibitor 
on the ability of transformed cells to form colonies in soft agar. Although this 
inhibitor does not influence the growth rate of transformed cells in liquid me- 
dium, it reduces the production of colonies in agar by more than 75 %  (Table V). 
Mouse Cells Transformed by Mouse Sarcoma  Virus or SV-40  Virus.-- 
Mouse sarcoma virus  (MSV):  To  obtain additional information  about  the 
possible general association of fibrinolytic activity with viral sarcomas we have 
examined the properties of murine embryo cells transformed by one of several 
types of virus. In  these  systems we have investigated the properties of  some 
normal and transformed cells on radioactive fibrin films, while others have been 
compared with respect to the activities of the serum-free supernatant fluids, or 
HF, from the respective cultures. 
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FIG. 3.  Morphology  of  SV40-transformed hamster  embryo  cells:  effects of  additional 
sera. Hamster embryo fibroblasts transformed by SV40 were plated at 2.5  X  105 cell  per 
60 mm dish in Dulbecco modified Eagle's medium containing 10% fetal bovine serum. After 
16 h  of incubation the cells were washed twice with the same medium containing 2%  of the 
appropriate serum and incubated for 72 h in medium containing 10% of the same serum. (a) 
SV40 hamster cells in  chicken serum medium;  (b)  SV-40 hamster cells  in  monkey serum 
medium; (c) SV40 hamster cells in dog serum medium. )<  66. 
TABLE  V 
The  Effect  of Soybean  Trypsin  Inhibitor  on  Hamster  SV-40-Transformed  Cells  Growing  in 
Liquid Medium and in A gar 
No. of cells per dish X IO  s  Plating efficiency  in 
Days after plating  i  --  2  3  4  5  agar 
% 
+  Soybean trypsin in-  0.16  0.52  3.9  6.0  5.1  3.9 
hibitor fraction VI 
No inhibitor  0.16  0.63  3.6  6.1  4.0  17.0 
Hamster SV-40-transformed cells were plated at 1 >(  10  '5 cells per 60 mm dish in medium 
containing 10% of fetal bovine serum. One group of cultures received l0/zg/ml of soybean 
trypsin inhibitor every day after plating; another group served as controls. Every day one 
control and one treated culture were trypsinized and the cells counted. On day 4  the tryp- 
sinized cells were plated in 0.33% agar (28) and the colonies that formed were counted after 
10 days. The inhibitor reduces growth of transformed cells in agar but not in liquid medium. 
cells is shown in Table I. These results are consistent with those of experiments 
in which HF's from the corresponding cultures are compared: as seen in Table 
VI, the HF from mouse cells transformed by  MSV gives rise to fibrinolytic ac- 
tivity when mixed with the appropriate serum; the HF  from normal cells does 
not. In this respect, therefore, mouse cell cultures resemble those obtained from 
hamster and chick embryos. Morover, the mouse system also shows a distinctive 
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TABLE VI 
Fibrinolytlc Activity of HF from Mouse Embryo Fibroblasts Transformed by Mouse Sarcoma 
Virus: Serum Specificity 
Test fluid  Serum  Radioactivity  released into 
solution (percent of total) 
Medium (serum free) 
Medium 
Normal mouse culture HF 
MSV-transformed  culture HF 
% 
0.6 
Dog  0.6 
Dog  0.8 
Dog  70.0 
Monkey  79.1 
Human  44.3 
Mouse  9.6 
Hamster  2.6 
Rat  0.6 
Pig  0.7 
Fetal pig  0.6 
Calf  0.5 
Fetal bovine  0.5 
Petri  dishes  (35  mm  diameter)  containing  [t25I]fibrin (10 #g/cm2;  5 X  104  cpm  total 
radioactivity) were prepared as described in Methods. Serum-free medium or HF (1 ml) was 
supplemented with the appropriate serum at a final concentration of 2.5% and the mixture 
incubated for 5 h at 37°C. 
hamster HF and chick HF behave similarly with mouse HF, whereas others do 
not (Table VI).  Again, fetal  bovine serum  and  chicken  serum  are inhibitory 
when added to media containing activating sera, and soybean trypsin inhibitor 
and NPGB block the enzyme derived from mouse cultures just as they do those 
originating in transformed hamster and chick cells (Table VII). 
Because  dog serum  effectively activates fibrinolysis with  either hamster  or 
mouse HF, whereas hamster serum does not, it appears likely that the pattern 
of specificity of activating sera is determined by some properties associated with 
the cell factor in the HF. Further evidence in support of this view is presented 
below. 
Mouse  cells,  3T3,  transformed  by SV-40:  Since mouse  cells may  be  trans- 
formed by both  MSV  and  SV-40,  a  comparison of such  transformed cultures 
might provide some preliminary indication regarding the possible viral or cellu- 
lar determination of the fibrinolytic enz3nne. Similar information might emerge 
from a comparison of the enzymes derived from two cell types, mouse and ham- 
ster, transformed by a single virus, SV-40. In common with all of the cell types 
described above,  transformed  SV-40-3T3  cells produce  a  protein factor  that 
generates  fibrinolytic activity on  interaction  with  appropriate  sera;  normal, 
untransformed 3T3  cells do not. This is shown in Table VIII, where the spec- 
trum of activating sera is seen to be identical with that  obtained with mouse 
embryo cells transformed by MSV. Also noteworthy is the failure of hamster 120  ENZYME  AND  ONCOGENIC  TRANSFORMATION 
serum  to  activate fibrinolysis with  SV-40-3T3  cell factor (HF),  Both of these 
facts  suggest  that  the  cell-derived factor  is  cell  specifc and  cell  determined, 
rather  than  virus  specific and/or  virus  determined. 
Ral Embryo Cells Transformed by B-77  Virus: Comparison wilh Transformed 
TABLE  VII 
Fibrinolysis by HF from MSV-Transformed Mouse Embryo Cells: l~ects of Inhibitors 
Radioactivity released into 
Serum  Inhibitor  solution (percent of total)  Percent  inhibition 
%  % 
A  Dog  None  26.0 
Dog  Fetal bovine serum, 5%  0.8  97.0 
Dog  Fetal hovine serum, 2.5c;}  5.6  88.5 
Dog  Fetal bovine serum, 1.0~  8.7  66.6 
Dog  Fetal bovine serum, 0.1%  19.9  24.5 
None  Fetal bovine serum, 1.0%  0.7 
Dog  Chicken serum, 5%  8.0  69.3 
Dog  Chicken serum, 2.5%  12.4  52.3 
Dog  Chicken serum, 1.0~  15.9  28.9 
Dog  Chicken serum, 0. lC}~  39.8  0 
None  Chicken serum, 1.0c.~  0.7 
B  Dog  None  63.0 
None  None  1.0 
Dog  STI  100 >g/ml  0.5  99 
Dog  STI  10/zg/ml  4.8  92 
Dog  STI  1/zg/ml  56.1  11 
Dog  NPGB  40 #g/ml  0.5  99 
Petri  dishes  (35  mm  diameter)  containing  [12:)I]fibrin (10  ~zg/cm2; total  radioactivity 
5 X  104 cpm) were prepared as descrihed in  Methods. The inhihitors were added at the de- 
sired final concentration to 1 ml of HF and the mixture supplemented, where indicated, with 
dog serum at a  final concentration of:  A,  1%  (vol/vol), or B,  2.5%.  The plates were then 
incubated for 3 h at 37°C and the radioactivity of the solution was assayed. 
TABLE  VIII 
Fibrinolysis by DiSerent HF's: Serum Specificity 
Radioactivity released into solution (percent of total) 
Cell origin of HF 
No serunl  l-)og serum  Mouse serum  Hamster serum 
q;~  ~  ';~  % 
3T3--Normal  1.9  2.5  0.9  NT* 
3T3--MSV  2.5  18.0  12.5  3.9 
3"1"3--SV-40  2.0  67.0  23.4  5.5 
Hamster--SV 40  2.7  63.2  35  60.2 
Petri  dishes  (35  mm  diameter)  containing  [l~aI]fibrin  (10  ~zg/cm~; total  radioactivity 
4 ;<  104 cpm) were prepared as described in Methods. The appropriate sera were added to 
1  ml  of  the respective HF's at a final concentration of 2.5%  (vol/vol) and the plates incu- 
bated for 6 h at 37°C, after which the solution was assayed for radioactivity. 
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Chick Cells.--Normal rat embryo cells do not produce fibrinolytic activity when 
plated onto [~25I]fibrin films, nor do they yield HF which generates such activity 
on  interaction with  serum-supplemented media.  However,  rat  embryo  cells 
transformed by B-77  virus (an avian sarcoma virus)  do produce fibrinolysin 
under both sets of conditions. The titer of enzyme is lower than obtained with 
hamster embryo or chick embryo fibroblasts transformed by SV-40 and RSV, 
respectively. However,  as seen in Table IX,  the activity is clearly present in 
HF  from  transformed rat  cultures,  and  the  spectrum of  activating sera  for 
rat-B77-transformed cells resembles that obtained for transformed mouse HF. 
Also presented in Table IX is the spectrum of activating sera for chick em- 
bryo fibroblast cultures transformed by the same strain of B-77 virus as that 
used to transform rat embryo cells. The behavior of the two types of cells with 
the same set of sera is different, although transformation was produced by the 
same virus in both; this is a  further indication that the properties of the cell 
factor  in HF  from  transformed cultures is  largely,  and  perhaps  exclusively, 
determined by the cell type that releases it into the medium, rather than by 
the transforming virus. In a preliminary experiment rat-B77-transformed cells 
were cocultivated with chick embryo cells, and new chick cells were infected 
with the virus released from the mixed cultures. The serum specificity for fibri- 
TABLE  IX 
Fibrinc,  lytic Activity of Rat and Chick Cells and HF from Cultures  Transformed by B77: Serum 
Specificity 
Radioactivity released into supernatant fluid (percent of total) 
Serum  A: Transformed cells  B: HF 
Chick-RSV B77  Rat-RSV B77  Chick-RSV B77  Rat-RSV B77 
%  %  %  % 
Dog  4.7  98.1  2.3  27.9 
Monkey  4.1  45.3  NT*  NT 
Chicken  32.7  3.0  NT  NT 
Fetal bovine  3.0  3.0  NT  NT 
No serum  3.0  3.0  1.1  4.6 
Comparison of chick embryo and rat embryo cells transformed by B77 virus: Petri dishes 
(60  mm  diameter)  containing  [125I]fibrin (10 #g/cm~:  total  radioactivity  1.8 X  10  G cpm) 
were prepared as described in Methods. The dishes were inoculated with 8 ;K 10  ~ cells per 
plate in each case and incubated for 16 h with medium containing fetal bovine serum 10% 
(vol/vol). After 16 h the medium was removed, the monolayer washed with TD, and fresh 
medium, containing the indicated  serum at a  final concentration  of 5%  was added. The 
cultures were incubated for a further 24 h and the medium was then assayed for radioactiv- 
ity. Comparison of HF's from chick and rat embryo cultures  transformed  by B77: Petri 
dishes (35 mm diameter) contained [12~I]fibrin  (10 #g/cm2; total radioactivity 3 X  104 cpm). 
The respective HF's (1 ml) were supplemented with  the  various sera  (final concentration 
2.5% vol/vol) and incubated at 37°C for 6 h (transformed chick cells) or 17 h (transformed 
rat cells), after  which the fluids were assayed for radioactivity. 
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nolytic activity generated by these ceils was similar to that of chick cells infected 
with B-77 propagated in chick cells. 
Humeri Sere, H~man Serum Factor, and Human Cells.--B ecause the extension 
and application of the preceding findings to human neoplasia is of obvious inter- 
est, we have begun to survery human sere and to examine primary cultures of 
human tumors for properties analogous to those described above for the  other 
cell types. The findings with human material will  be presented in  detail  in  a 
separate communication, but they are summarized here briefly as follows. 
(a)  Most human sere behave, like monkey serum, as activating sere with HF 
from various cells,  although the efficiency of "activation" is not uniform with 
different transformed cells and their respective HF's. 
(b)  In purification procedures the human serum factor that participates in 
fibrinolvsis fractionates in a manner similar to the chicken serum factor. 
(c)  Certain  human  sere,  including  some from  tumor-bearing  patients,  are 
nonactivating; these are in fact inhibitory, in analog}' with the sere of tumor- 
bearing chickens. 
(d)  In preliminary experiments a  single human  carcinoma has so far been 
maintained and slowly propagated in primary culture.  This tumor shows fibri- 
nolytic activity when the cells are in contact with [~sI]fibrin films. Primary cul- 
tures  of human  embryo fibroblasts  produce  no  detectable  fibrinolysis  under 
identical conditions. 
DISCUSSION AND  CONCLUSIONS 
The preceding results support the following  tentative conclusions. 
(a)  Virus-transformed cells derived fl'om at least four species, chicken, ham- 
ster, mouse, and rat, give rise to fibrinolytic activity when the growth media 
are  supplemented  with  appropriate  sera.  Cultures  of normal,  untransformed 
cells do not produce any comparable enzymatic activity, and this fibrinolysin 
therefore represents an important and qualitative enzymatic difference between 
normal and virus-transformed cells. 
(b)  The tibrinolysin is generated by the interaction  of two protein factors, 
neither of which shows activity alone. One of these is a protein that is released 
into  culture  media by transformed cells  and  by primary cultures  of  chicken 
sarcomas, and the second is a protein that is found in sere of numerous verte- 
brate  species,  including  man.  The  difference  in  fibrinolytic activity between 
normal  and  transformed cultures  is based on  the fact that  transformed cells 
release a  cell factor that is not released, or is released in much lower concen- 
trations by normal cultures. Quantitative estimates, derived from titrations of 
HF fronl both normal and RSV-transformed chick cultures, show that normal 
HF contains less than 5 % of the cell factor found in the transformed HF. 
The following tentative nomenclature is proposed, pending elucidation of the 
enzymatic mechanism and  biological  role of the  two protein  factors: for the 
overall enzymatic activity, the designation fibrinolysin T; for the factor pro- OSSOWSKI,  LrNKELESS,  TOBIA,  QUIGLEY,  RII~KIN,  REICH  123 
duced by transformed cells, fibrinolysin To; and for the serum factor, fibrinol- 
ysin Ts.  An enzymatic activity produced by the  interaction  of  transformed 
chick HF and monkey serum (or the respective purified factors) would be desig- 
q~C: Chick  nated fibrinolysin *s: Monkey. 
(C)  The production of the cell factor, and therefore fibrinolytic activity, is 
closely correlated with morphological evidence of transformation as shown by 
the behavior of cultures infected with a mutant of RSV that is temperature- 
sensitive for cell transformation. The emergence of fibrinolytic activity requires 
the synthesis of RNA and protein after transfer of such cultures to permissive 
conditions. Moreover, fibrinolytic activity is also correlated with a  change in 
morphology of hamster cultures transformed by SV-40 virus. The role of the 
enzyme in the development of the transformed state therefore deserves careful 
study. 
(d)  It is noteworthy that cultures transformed by DNA (SV-40) and RNA 
viruses (RSV, MSV, B-77) produce similar kinds of fibrinolytic activities. This 
raises the possibility that  the virus-stimulated cellular response which cuhni- 
nares in  transformation may involve a  very small  number,  or even a  single 
enzymatic pathway as an obligatory comnlon element. 
(e)  The spectrum of sera that are effective in producing fibrinolytic activity 
differs according to the transformed cell type from which the cell factor is de- 
rived. This aspect of specificity therefore appears to be governed by the nature 
of the cell  rather than by the virus. Thi~ conclusion is supported by a  com- 
parison of (i)  rat and chick cells  transformed by B-77 virus, (ii)  mouse cells 
transformed by MSV or SV-40,  and (iii)  mouse and hamster cells transformed 
by SV-40. 
(f)  The sera of normal chickens give rise to a fibrinolysin after interaction 
with a factor produced by cultures of transformed chick embryo cells, whereas 
sera obtained from birds infected with RSV do not. The failure of sera from 
tumor-bearing chickens to produce fibrinolytic activity under these conditions  3 
is due to the presence of an inhibitor of the overall fibrinolytic reaction. We do 
not know whether this inhibitor is directed against the transformed cell factor, 
the serum factor, the product of their interaction, or a subsequent step in the 
reaction sequence that ultimately yields fibrinolysis. Nevertheless, the fact that 
all of the tested sera from tumor-bearing fowl are inhibitory to fibrinolysis, while 
all of those from normal fowl are activating, suggests (i)  that the inhibitor is 
formed by the host in response to the tumor, and (ii)  that it could play an im- 
portant part in the frequent regression of avian sarcomas. The presence of a 
similar inhibitory activity in the serum of some tumor-bearing patients is also 
consistent with the hypothesis that this may be the expression of a natural de- 
fense mechanism. 
a In addition to the inhibitory protein the sera of tumor-bearing animals also contain the 
activating factor that is present in normal sera. The activating serum factor is readily sepa- 
rated from the inhibitor by ammonium sulfate fractionation. 124  ENZYME  ANY; ONCOGENIC TRANSFORMATION 
On the basis of the preceding data we cannot know which molecule is actually 
responsible for fibrinolysis: it could be either the cell factor, the serum factor, a 
product resulting  from their interaction,  or another protein(s)  contaminating 
the fibrinogen or fibrin. Moreover, it remains unclear whether fibrin is a normal 
substrate for the hydrolytic enzyme in question, and what is the relationship, if 
any, to the serum and other factors that have been investigated in other labo- 
ratories  (25).  Finally,  the  relationship  of  this  fibrinolytic activity to  that  of 
plasmin  4 nmst be defined precisely; the data obtained to date with several sera 
indicate  that  there  are differences in  the  two  activities.  Therefore, while  the 
observations described in this paper invite speculation and comment, it seems 
appropriate to defer further discussion  pending  clarification of relevant ques- 
tions, some of which form the subject of current experiments. 
SUMMARY 
Chick, hamster, mouse, and rat embrvo fibroblast cultures,  transformed by 
either DNA or RNA viruses, show fibrinolytic activity under suitable condi- 
tions of growth and in appropriate media; normal counterpart cultures do not. 
The fibrinolysin is produced bv the interaction  of two protein factors: one of 
these,  a  cell  factor,  is  released  by transformed  cells  and  accumulates in  the 
medium when cultures are incubated in the absence of sermn. The second factor, 
the serum factor, is a specifc protein that is present in sera of many  avian and 
mammalian species, including man. 
Not all sera yield fibrinolysin on interaction with any given transformed cell 
factor,  and  the  spectrum of activating sera is distinctive for each  cell  factor. 
This pattern  appears to be determined  by the  cell  type,  rather  than  bv the 
transforming virus. 
An  important  role for the fibrinolysin  in  oncogenic  transformation  is  sug- 
gested bv the following correlations.  (a) The initial  appearance of fibrinolysin 
precedes the morphological change after the transfer to permissive temperatures 
of  chick fibroblast  cultures  infected  with  a  temperature-sensitive  nmtant  of 
RSV. (b) The initiation of fibrinolysis and of morphological change both require 
the synthesis of new protein, but not the synthesis of either DNA  or rRNA. 
(c) The activity of the fibrinolysin is correlated with the retention  of abnormal 
morphology in  hamster  cells  transformed by SV-40.  (d)  The  sera  of normal 
chicks  effectively activate fibrinolysis  with  the  cell  factor from transformed 
chick cells. In contrast the sera of chicks with RSV tunmrs do not; these contain 
an inhibitor of the fibrinolytic activity. 
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Note Added in Proof.--Since this manuscript was submitted for publication we have 
found that a cell factor is also produced by (a) primary cultures of dimethylbenzan- 
thracene-induced rat  mammary  carcinomas,  (b)  mouse  fibroblasts transformed  by 
methylcholanthrene, and (c) several human tumor cell lines. The properties of these 
cell factors  closely resemble  those  obtained  from  transformed  chick  and  hamster 
fibroblast cultures. 
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